Sun Pharma dips 4% as CLSA says valuations expensive, margin pressure to continue News News / News 6 years ago 439 Views comments CLSA said building on speciality product pipeline is a strategy in the right direction but monetisation of speciality product pipeline is some time aw... Read more
News Most Asia markets pressured after North Korea missile, dollar recoups losses News / News - 6 years ago
News Rajnath, Sushma to brief opposition on China stand-off, Jammu and Kashmir News / News - 6 years ago
Comments